Anand Patel to Lymphoma, B-Cell
This is a "connection" page, showing publications Anand Patel has written about Lymphoma, B-Cell.
Connection Strength
0.768
-
Outcomes After Retreatment With Inotuzumab Ozogamicin for Relapsed/Refractory Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia. JCO Precis Oncol. 2022 10; 6:e2200353.
Score: 0.768